# A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity

> **NCT01586117** · PHASE2 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 40 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Amifostine

## Key facts

- **NCT ID:** NCT01586117
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01586117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01586117, "A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01586117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*